Toxic Cardiogenic Shock in a Patient Receiving Weekly 24-h Infusion of High-dose 5-Fluorouracil and Leucovorin

Japanese Journal of Clinical Oncology

Volumn 28, Issue 9, 1998, Pages 551-554

  Wang, Wei Shu ^a,b   Hsieh, Ruey Kuen ^a   Chiou, Tzeon Jye ^a   Liu, Jin Hwang ^a   Fan, Frank S ^a   Yen, Chueh Chuan ^a   Tung, Shiao Lin ^a   Chen, Po Min ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

5 fluorouracil; Cardiogenic shock; Colon cancer; Weekly high dose

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; FU CF PROTOCOL; FU-CF PROTOCOL;

ACUTE DISEASE; ARTICLE; CARDIOGENIC SHOCK; CASE REPORT; CHEMICALLY INDUCED DISORDER; COLON RESECTION; COLON TUMOR; DRUG ADMINISTRATION; ELECTROCARDIOGRAPHY; HUMAN; LUNG EDEMA; MALE; MIDDLE AGED;

ACUTE DISEASE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLECTOMY; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; PULMONARY EDEMA; SHOCK, CARDIOGENIC; SIGMOID NEOPLASMS;

EID: 0032160072     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/28.9.551     Document Type: Article

References (16)

1. Buroker TR, Moertel CG, Fleming TR. A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma. J Clin Oncol 1985;3:1624-31.
2. Labianca R, Beretta G, Clerici M, Fraschini P, Luporini G. Cardiac toxicity of 5-fluorouracil: a study of 1083 patients. Tumori 1982;68:505-10
3. Freeman NJ, Costanza ME. 5-Fluorouracil-associated cardiotoxicity. Cancer 1988,61:36-45.
4. McKendall GR, Shurman A, Anamur M, Most AS. Toxic cardiogenic shock associated with infusion of 5-fluorouracil. Am Heart J 1989;118:184-6.
5. Erlichman C, Fine S, Wong A, Elhakim T. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal cancer. J Clin Oncol 1988;6:469-75.
6. Ardalan B, Chua L, Tian EM, Reddy R, Sridhar K, Benedetto P, et al. A phase II study of weekly 24-h infusion with high-dose fluorouracil with leucovorin in colorectal carcinoma. J Clin Oncol 1994;9:625-30.
7. Kohne CH, Thuss-Patience P, Friedrich M, Daniel PT, Kretzschmar A, Benter T, et al. Raltitrexed(Tomudex): an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxcity. Br J Cancer 1998;77:973-7.
8. Dent R, McColl I. 5-Fluorouracil and angina. Lancet 1975,1:347-8.
9. Ensley J, Kish J, Tapazoglou E. 5-Fluorouracil infusions associated with an ischemic cardiotoxicity syndrome. Proc Am Soc Clin Oncol 1986;5:142.
10. de Forni M, Malet-Martino MC, Jaillais P, Shubinski RE, Bachaud JM, Lemaire L, et al. Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective study. J Clin Oncol 1992;10:1795-801.
11. Coronel B, Madonna O, Mercatello A, Caillette A, Moskovtchenko JF. Myocardiotoxicity of 5-fluorouracil. Intensive Care Med 1988;14:429-30.
12. Jakubowski AA, Kemeny N. Hypotension as a manifestation of cardiotoxicity in three patients receiving cisplatin and 5-fluorouracil. Cancer 1988;62:266-9.
13. Robben NC, Pippas AW, Moore JO. The syndrome of 5-fluorouracil cardiotoxocity. Cancer 1993;71:493-509.
14. Stevenson DL, Mikhailidis DP, Gillett DS Cardiotoxicity of 5-fluorouracil Lancet 1977;2 406-7.
15. Villani F, Guindani A, Pagnoni A. 5-Fluorouracil cardiotoxicity. Tumori 1979;65:487-95.
16. Loene B, Rabinovich M, Ferrari CR, Boyer J, Rosso H, Strauss E Cardiotoxicity as a result of 5-fluorouracil therapy. Tumori 1985,71:55-7.